Profile
Adam Shilling worked as an Executive Director of Global Regulatory Affairs at Incyte Corp.
He then worked as a Vice President of Early Development at Prelude Therapeutics, Inc. from 2019 to 2022.
Mr. Shilling received an undergraduate degree from Long Island University and a doctorate degree from Oregon State University.
Former positions of Adam Shilling
| Companies | Position | End |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | General Counsel | 01/04/2022 |
| INCYTE CORPORATION | General Counsel | - |
Training of Adam Shilling
| Long Island University | Undergraduate Degree |
| Oregon State University | Doctorate Degree |
Experiences
Positions held
Connections
14
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
- Stock Market
- Insiders
- Adam Shilling
